Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

monoclonal antibody KW-2871

Known as: Chimeric Monoclonal Antibody KW-2871, ECROMEXIMAB, Immunoglobulin G1, Anti-(Gd3 Ganglioside) (Human-Mouse Monoclonal Km871 Gamma-1-Chain), Disulfide with Human-Mouse Monoclonal KM871 Kappa-Chain, Dimer 
A low-fucose, human-mouse chimeric IgG1 monoclonal antibody with potential antineoplastic activity targeting at the ganglioside GD3, a surface… Expand
National Institutes of Health

Related topics

Related topics

4 relations
Antibody-Dependent Cellular CytotoxicityKM871 monoclonal antibodyKW-2871antigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-&agr;2b in patients with metastatic melanoma
This study evaluated the safety and clinical benefit of ecromeximab (KW2871) combined with high-dose interferon-&agr;2b (HDI) in… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE